ProCE Banner Activity

MAVMET: Maraviroc ± Metformin for the Treatment of NAFLD in Virologically Suppressed Adults With HIV

Slideset Download
Conference Coverage
Maraviroc ± metformin, in addition to ART, was safe with acceptable tolerability but did not reduce liver fat percentage vs no adjunctive treatment.

Released: November 03, 2021

Expiration: November 02, 2022

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare